Nitric oxide
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Beyond Air Inc.
Overview
Nitric oxide is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Nitric oxide clinical trials
Explore related
Medical disclaimer. This page summarizes research about Nitric oxide for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.